<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetes Ther</journal-id><journal-id journal-id-type="iso-abbrev">Diabetes Ther</journal-id><journal-title-group><journal-title>Diabetes Therapy</journal-title></journal-title-group><issn pub-type="ppub">1869-6953</issn><issn pub-type="epub">1869-6961</issn><publisher><publisher-name>Springer Healthcare</publisher-name><publisher-loc>Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25707480</article-id><article-id pub-id-type="pmc">4374074</article-id><article-id pub-id-type="publisher-id">101</article-id><article-id pub-id-type="doi">10.1007/s13300-015-0101-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Erratum</subject></subj-group></article-categories><title-group><article-title>Erratum to: Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Ommen</surname><given-names>Elizabeth S.</given-names></name><address><email>elizabeth.ommen@merck.com</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>O&#x02019;Neill</surname><given-names>Edward A.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Goldstein</surname><given-names>Barry J.</given-names></name><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Kaufman</surname><given-names>Keith D.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Engel</surname><given-names>Samuel S.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Merck &#x00026; Co., Inc., Whitehouse Station, NJ USA </aff><aff id="Aff2"><label/>Clinical Research Department, Merck Research Laboratories, RY34-A214, Rahway, NJ 07065 USA </aff><aff id="Aff3"><label/>Covance, Inc., Princeton, NJ USA </aff></contrib-group><pub-date pub-type="epub"><day>24</day><month>2</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>24</day><month>2</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2015</year></pub-date><volume>6</volume><issue>1</issue><fpage>97</fpage><lpage>98</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2015</copyright-statement></permissions><related-article related-article-type="corrected-article" id="d30e89" ext-link-type="doi" xlink:href="10.1007/s13300-015-0098-y"/><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Healthcare 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Erratum to: Diabetes Ther (2015) DOI 10.1007/s13300-015-0098-y</title><p>In Table&#x000a0;2, in the first column, the third row should read &#x0201c;60 to &#x0003c;90 by CKD-epi&#x0201d; and the fourth row should read &#x0201c;&#x02265;90 by CKD-epi&#x0201d; and in the fourth column the first row should read &#x0201c;&#x02265;90 by MDRD&#x0201d;.<table-wrap id="Tab1"><label>Table&#x000a0;2 </label><caption><p>The glomerular filtration rates of all subjects in Study 3 were estimated using both the 4-variable Modification of Diet in Renal Disease (MDRD) equation and the Chronic Kidney Disease Epidemiology Collaboration (CKD-epi) creatinine equation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Subject eGFR classification</th><th align="left">&#x0003c;60 by MDRD</th><th align="left">60 to &#x0003c;90 by MDRD</th><th align="left">&#x02265;90 by MDRD</th><th align="left">Total</th></tr></thead><tbody><tr><td align="left">&#x0003c;60 by CKD-epi</td><td char="(" align="char">49 (4.7)</td><td char="(" align="char">3 (0.3)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">52 (5.0)</td></tr><tr><td align="left">60 to &#x0003c;90 by CKD-epi</td><td char="(" align="char">6 (0.6)</td><td char="(" align="char">489 (47.2)</td><td char="(" align="char">16 (1.5)</td><td char="(" align="char">511 (49.4)</td></tr><tr><td align="left">&#x02265;90 by CKD-epi</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">29 (2.8)</td><td char="(" align="char">443 (42.8)</td><td char="(" align="char">472 (45.6)</td></tr><tr><td align="left">Total</td><td char="(" align="char">55 (5.3)</td><td char="(" align="char">521 (50.3)</td><td char="(" align="char">459 (44.3)</td><td char="(" align="char">1035 (100.0)</td></tr></tbody></table><table-wrap-foot><p>A comparison of the results of subject classification [<italic>n</italic> (%)] based on the results of each method is displayed</p></table-wrap-foot></table-wrap></p></sec></body><back><fn-group><fn><p>The online version of the original article can be found under doi:10.1007/s13300-015-0098-y.</p></fn></fn-group><ack><title>Open Access</title><p>This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</p></ack></back></article>